UPDATE 1-Vertex cystic fibrosis drug to be available in England after pricing deal

Cystic fibrosis patients in England will have access to life-extending drugs after the state-funded health service said it had agreed a pricing deal with manufacturer Vertex Pharmaceuticals. England’s National Health Service (NHS) has been negotiating with Vertex for years about supplying Orkambi, a combination drug that improves lung function. The U.S. company had wanted to charge around 100,000 pounds ($129,000) a year for a course of Orkambi, according to reports. …read more

Source:: Yahoo Finance


Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.